Transcept Pharmaceuticals, Inc. (TSPT) Posts Q2 Loss of 17c
Tweet
Share
E-mailGet Alerts TSPT Hot Sheet
Join SI Premium – FREE
Transcept Pharmaceuticals, Inc. (NASDAQ: TSPT) reported Q2 loss of ($0.17), $0.06 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $3.13 million versus the consensus estimate of $2.08 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
